Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 26(8)2021 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-33921501

RESUMEN

Prostate cancer is a very common disease, which is, unfortunately, often the cause of many male deaths. This is underlined by the fact that the early stages of prostate cancer are often asymptomatic. Therefore, the disease is usually detected and diagnosed at late advanced or even metastasized stages, which are already difficult to treat. Hence, it is important to pursue research and development not only in terms of novel diagnostic methods but also of therapeutic ones, as well as to increase the effectiveness of the treatment by combinational medicinal approach. Therefore, in this review article, we focus on recent approaches and novel potential tools for the treatment of advanced prostate cancer; these include not only androgen deprivation therapy, antiandrogen therapy, photodynamic therapy, photothermal therapy, immunotherapy, multimodal therapy, but also poly(ADP-ribose) polymerase, Akt and cyclin-dependent kinase inhibitors.


Asunto(s)
Neoplasias de la Próstata/terapia , Animales , Antineoplásicos Hormonales/química , Antineoplásicos Hormonales/farmacología , Antineoplásicos Hormonales/uso terapéutico , Ensayos Clínicos como Asunto , Terapia Combinada , Humanos , Inmunoterapia , Masculino , Fototerapia , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/inmunología
2.
Biomolecules ; 10(12)2020 12 05.
Artículo en Inglés | MEDLINE | ID: mdl-33291419

RESUMEN

In spite of the impressing cytotoxicity of thapsigargin (Tg), this compound cannot be used as a chemotherapeutic drug because of general toxicity, causing unacceptable side effects. Instead, a prodrug targeted towards tumors, mipsagargin, was brought into clinical trials. What substantially reduces the clinical potential is the limited access to Tg and its derivatives and cost-inefficient syntheses with unacceptably low yields. Laser trilobum, which contains a structurally related sesquiterpene lactone, trilobolide (Tb), is successfully cultivated. Here, we report scalable isolation of Tb from L. trilobum and a transformation of Tb to 8-O-(12-aminododecanoyl)-8-O-debutanoylthapsigargin in seven steps. The use of cultivated L. trilobum offers an unlimited source of the active principle in mipsagargin.


Asunto(s)
Antineoplásicos Fitogénicos/química , Apiaceae/química , Butiratos/química , Técnicas de Química Sintética , Furanos/química , Tapsigargina/análogos & derivados , Antineoplásicos Fitogénicos/aislamiento & purificación , Apiaceae/metabolismo , Butiratos/aislamiento & purificación , Dióxido de Carbono/química , Cromatografía con Fluido Supercrítico/métodos , Frutas/química , Frutas/metabolismo , Furanos/aislamiento & purificación , Humanos , Estructura Molecular , Neoplasias/tratamiento farmacológico , Neoplasias/patología , Extractos Vegetales/química , ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico/antagonistas & inhibidores , ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico/metabolismo , Tapsigargina/aislamiento & purificación
3.
Molecules ; 25(17)2020 Aug 24.
Artículo en Inglés | MEDLINE | ID: mdl-32847100

RESUMEN

Some aromatic polyketides such as dietary flavonoids have gained reputation as miraculous molecules with preeminent beneficial effects on human health, for example, as antioxidants. However, there is little conclusive evidence that dietary flavonoids provide significant leads for developing more effective drugs, as the majority appears to be of negligible medicinal importance. Some aromatic polyketides of limited distribution have shown more interesting medicinal properties and additional research should be focused on them. Combretastatins, analogues of phenoxodiol, hepatoactive kavalactones, and silymarin are showing a considerable promise in the advanced phases of clinical trials for the treatment of various pathologies. If their limitations such as adverse side effects, poor water solubility, and oral inactivity are successfully eliminated, they might be prime candidates for the development of more effective and in some case safer drugs. This review highlights some of the newer compounds, where they are in the new drug pipeline and how researchers are searching for additional likely candidates.


Asunto(s)
Antioxidantes , Flavonoides , Policétidos , Antioxidantes/química , Antioxidantes/uso terapéutico , Ensayos Clínicos como Asunto , Flavonoides/química , Flavonoides/uso terapéutico , Humanos , Policétidos/química , Policétidos/uso terapéutico
4.
Ann Hepatol ; 13(2): 273-83, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24552870

RESUMEN

Spirulina platensis is a blue-green alga used as a dietary supplement because of its hypocholesterolemic properties. Among other bioactive substances, it is also rich in tetrapyrrolic compounds closely related to bilirubin molecule, a potent antioxidant and anti-proliferative agent. The aim of our study was to evaluate possible anticancer effects of S. platensis and S. platensis-derived tetrapyrroles using an experimental model of pancreatic cancer. The anti-proliferative effects of S. platensis and its tetrapyrrolic components [phycocyanobilin (PCB) and chlorophyllin, a surrogate molecule for chlorophyll A] were tested on several human pancreatic cancer cell lines and xenotransplanted nude mice. The effects of experimental therapeutics on mitochondrial reactive oxygen species (ROS) production and glutathione redox status were also evaluated. Compared to untreated cells, experimental therapeutics significantly decreased proliferation of human pancreatic cancer cell lines in vitro in a dose-dependent manner (from 0.16 g•L-1 [S. platensis], 60 µM [PCB], and 125 µM [chlorophyllin], p<0.05). The anti-proliferative effects of S. platensis were also shown in vivo, where inhibition of pancreatic cancer growth was evidenced since the third day of treatment (p < 0.05). All tested compounds decreased generation of mitochondrial ROS and glutathione redox status (p = 0.0006; 0.016; and 0.006 for S. platensis, PCB, and chlorophyllin, respectively). In conclusion, S. platensis and its tetrapyrrolic components substantially decreased the proliferation of experimental pancreatic cancer. These data support a chemopreventive role of this edible alga. Furthermore, it seems that dietary supplementation with this alga might enhance systemic pool of tetrapyrroles, known to be higher in subjects with Gilbert syndrome.


Asunto(s)
Antineoplásicos/farmacología , Bilirrubina/farmacología , Proliferación Celular/efectos de los fármacos , Neoplasias Pancreáticas/patología , Extractos Vegetales/farmacología , Spirulina , Tetrapirroles/farmacología , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Humanos , Técnicas In Vitro , Ratones , Ratones Desnudos , Oxidación-Reducción , Neoplasias Pancreáticas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Trasplante Heterólogo , Ensayos Antitumor por Modelo de Xenoinjerto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA